Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma
- PMID: 22783418
- PMCID: PMC3392596
- DOI: 10.3892/ol.2012.670
Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma
Abstract
Post-transplant lymphoproliferative disorders (PTLDs) are lymphoid or plasmacytic proliferations that develop as a consequence of immunosuppression in a recipient of a solid organ, bone marrow or stem cell allograft. The development of PTLDs is usually associated with Epstein-Barr virus (EBV) and the disorder is also termed EBV-associated lymphoproliferative disorder (LPD). The development of PTLD is a rare complication in autologous bone marrow/peripheral blood stem cell transplantation. In the present study, we report a case of EBV-associated LPD which developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma. A 51-year-old male presented with swelling of the left cervical lymph nodes. A biopsy revealed nodular sclerosis classical Hodgkin's lymphoma. Following four courses of ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) therapy, the Hodgkin's lymphoma relapsed. CHASE (cyclophosphamide, etoposide, cytarabine, dexamethasone) therapy and autologous peripheral blood stem cell transplantation were performed. In the 128 days following the transplantation, lymph node swelling was noted and a biopsy specimen demonstrated EBV-associated LPD. The serum copy number of EBV-DNA was 2.7×10(3) copies/ml. The occurrence of EBV-associated LPD may be on the rise due to the increased number of patients undergoing immunosuppression therapy. The measurement of the serum EBV-DNA copy number and the detection of EBV-infected atypical lymphocytes using in situ hybridization are significant in establishing an early accurate diagnosis and initiating the correct treatment for EBV-associated LPD in patients with immunosuppression.
Figures





Similar articles
-
T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.Diagn Pathol. 2020 Oct 9;15(1):125. doi: 10.1186/s13000-020-01038-3. Diagn Pathol. 2020. PMID: 33036636 Free PMC article.
-
Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.Leuk Res. 2006 Aug;30(8):1059-62. doi: 10.1016/j.leukres.2005.10.022. Epub 2005 Dec 2. Leuk Res. 2006. PMID: 16330097
-
Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease.Bone Marrow Transplant. 2000 Dec;26(12):1339-41. doi: 10.1038/sj.bmt.1702721. Bone Marrow Transplant. 2000. PMID: 11223975
-
Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.Int J Clin Exp Pathol. 2014 Mar 15;7(4):1748-54. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24817974 Free PMC article. Review.
-
Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.Transpl Infect Dis. 2001 Sep;3(3):177-85. doi: 10.1034/j.1399-3062.2001.003003177.x. Transpl Infect Dis. 2001. PMID: 11493400 Review.
Cited by
-
T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.Diagn Pathol. 2020 Oct 9;15(1):125. doi: 10.1186/s13000-020-01038-3. Diagn Pathol. 2020. PMID: 33036636 Free PMC article.
-
Immune reconstitution after allogeneic hematopoietic stem cell transplantation in children: a single institution study of 59 patients.Korean J Pediatr. 2013 Jan;56(1):26-31. doi: 10.3345/kjp.2013.56.1.26. Epub 2013 Jan 29. Korean J Pediatr. 2013. PMID: 23390442 Free PMC article.
-
Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.Int J Clin Exp Pathol. 2013 Sep 15;6(10):2237-41. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24133604 Free PMC article.
References
-
- Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC; Lyon: 2008. pp. 343–349.
-
- Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2003;4:222–230. - PubMed
-
- Bakker NA, van Imhoff GW, Verschuuren EA, et al. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant. 2005;19:327–334. - PubMed
-
- Caillard S, Lelong C, Pessione F, Moulin B. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant. 2006;6:2735–2742. - PubMed
-
- Nash RA, Dansey R, Storek J, et al. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-seletcted hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant. 2003;9:583–591. - PMC - PubMed
LinkOut - more resources
Full Text Sources